213 related articles for article (PubMed ID: 15927260)
21. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
[TBL] [Abstract][Full Text] [Related]
22. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844
[TBL] [Abstract][Full Text] [Related]
23. Toward understanding the chloroquine action at the molecular level in antimalarial therapy--X-ray absorption studies in acetic acid solution.
Walczak MS; Lawniczak-Jablonska K; Wolska A; Sikora M; Sienkiewicz A; Suárez L; Kosar AJ; Bellemare MJ; Bohle DS
J Phys Chem B; 2011 Apr; 115(15):4419-26. PubMed ID: 21434658
[TBL] [Abstract][Full Text] [Related]
24. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.
Tripathi AK; Gupta A; Garg SK; Tekwani BL
Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of synthetic beta-haematin and effects of the antimalarial drugs quinidine, halofantrine, desbutylhalofantrine and mefloquine on its formation.
Egan TJ; Hempelmann E; Mavuso WW
J Inorg Biochem; 1999; 73(1-2):101-7. PubMed ID: 10212997
[TBL] [Abstract][Full Text] [Related]
26. A physiochemical mechanism of hemozoin (beta-hematin) synthesis by malaria parasite.
Tripathi AK; Garg SK; Tekwani BL
Biochem Biophys Res Commun; 2002 Jan; 290(1):595-601. PubMed ID: 11779214
[TBL] [Abstract][Full Text] [Related]
27. Hematin-hematin self-association states involved in the formation and reactivity of the malaria parasite pigment, hemozoin.
Klonis N; Dilanian R; Hanssen E; Darmanin C; Streltsov V; Deed S; Quiney H; Tilley L
Biochemistry; 2010 Aug; 49(31):6804-11. PubMed ID: 20593810
[TBL] [Abstract][Full Text] [Related]
28. Quinolines and structurally related heterocycles as antimalarials.
Kaur K; Jain M; Reddy RP; Jain R
Eur J Med Chem; 2010 Aug; 45(8):3245-64. PubMed ID: 20466465
[TBL] [Abstract][Full Text] [Related]
29.
Singh R; Singh R; Srihari V; Makde RD
ACS Infect Dis; 2023 Aug; 9(8):1647-1657. PubMed ID: 37471056
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
[TBL] [Abstract][Full Text] [Related]
31. Spectrally Resolved and Highly Parallelized Raman Difference Spectroscopy for the Analysis of Drug-Target Interactions between the Antimalarial Drug Chloroquine and Hematin.
Wolf S; Domes R; Domes C; Frosch T
Anal Chem; 2024 Feb; 96(8):3345-3353. PubMed ID: 38301154
[TBL] [Abstract][Full Text] [Related]
32. Phase homogeneity and crystal morphology of the malaria pigment beta-hematin.
Bohle DS; Kosar AD; Stephens PW
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 1):1752-6. PubMed ID: 12351900
[TBL] [Abstract][Full Text] [Related]
33. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.
Egan TJ; Hunter R; Kaschula CH; Marques HM; Misplon A; Walden J
J Med Chem; 2000 Jan; 43(2):283-91. PubMed ID: 10649984
[TBL] [Abstract][Full Text] [Related]
34. Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs.
Trang DT; Huy NT; Uyen DT; Sasai M; Shiono T; Harada S; Kamei K
Anal Biochem; 2006 Feb; 349(2):292-6. PubMed ID: 16376288
[TBL] [Abstract][Full Text] [Related]
35. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin.
Baelmans R; Deharo E; Muñoz V; Sauvain M; Ginsburg H
Exp Parasitol; 2000 Dec; 96(4):243-8. PubMed ID: 11162377
[TBL] [Abstract][Full Text] [Related]
36. Resonance Raman spectroscopy reveals new insight into the electronic structure of beta-hematin and malaria pigment.
Wood BR; Langford SJ; Cooke BM; Lim J; Glenister FK; Duriska M; Unthank JK; McNaughton D
J Am Chem Soc; 2004 Aug; 126(30):9233-9. PubMed ID: 15281812
[TBL] [Abstract][Full Text] [Related]
37. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs.
Fitch CD
Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191
[TBL] [Abstract][Full Text] [Related]
38. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay.
Tekwani BL; Walker LA
Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198
[TBL] [Abstract][Full Text] [Related]
39. Understanding chloroquine action at the molecular level in antimalarial therapy: X-ray absorption studies in dimethyl sulfoxide solution.
Walczak MS; Lawniczak-Jablonska K; Wolska A; Sienkiewicz A; Suárez L; Kosar AJ; Bohle DS
J Phys Chem B; 2011 Feb; 115(5):1145-50. PubMed ID: 21190356
[TBL] [Abstract][Full Text] [Related]
40. Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite.
Portela C; Afonso CM; Pinto MM; Ramos MJ
Bioorg Med Chem; 2004 Jun; 12(12):3313-21. PubMed ID: 15158799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
